ESC 365 - The Influence of post-implant antithrombotic drug therapy on the incidence of device thrombus and stroke in the AMULET-Registry Study

EHRA Premium Access

The Influence of post-implant antithrombotic drug therapy on the incidence of device thrombus and stroke in the AMULET-Registry Study

Session: Late Breaking Trial Session - Left atrial appendage occlusion

Topic: Automatic implantable cardioverter / defibrillator

Speaker: Doctor B. Schmidt (Frankfurt, DE)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Boris Schmidt

Cardioangiologisches Centrum Bethanien, Frankfurt (Germany)

18 presentations

0 follower

2 more presentations in this session

Thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis

Speaker: Professor L. Fauchier (Tours, FR)

Left atrial appendage occlusion - Discussion.

Access the full session

Late Breaking Trial Session - Left atrial appendage occlusion

Speakers: Doctor B. Schmidt, Professor L. Fauchier

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources